Biomerica, Inc. (OTCMKTS:BMRA) was downgraded by equities researchers at ValuEngine from a “hold” rating to a “sell” rating in a report issued on Friday.
Biomerica (OTCMKTS:BMRA) opened at 2.72 on Friday. The firm’s market capitalization is $23.14 million. The firm’s 50-day moving average is $2.66 and its 200-day moving average is $2.49. Biomerica has a 12 month low of $1.53 and a 12 month high of $3.38.
WARNING: This article was first posted by Transcript Daily and is owned by of Transcript Daily. If you are reading this article on another publication, it was stolen and reposted in violation of US & international copyright and trademark laws. The original version of this article can be accessed at https://transcriptdaily.com/2017/08/13/valuengine-downgrades-biomerica-inc-otcmktsbmra-to-sell.html.
Biomerica Company Profile
Biomerica, Inc is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company’s medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of care (physicians’ offices and over-the-counter drugstores).
Receive News & Ratings for Biomerica Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica Inc. and related companies with MarketBeat.com's FREE daily email newsletter.